Brazil Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Brazil Cardiovascular Devices Market Trends and it is segmented by device type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices).

Brazil Cardiovascular Devices Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
brazil cardiovascular devices market analysis
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 2.50 %

Major Players

brazil cardiovascular devices market major players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Brazil Cardiovascular Devices Market Analysis

The Brazil Cardiovascular Devices Market is expected to register a CAGR of 2.5% during the forecast period. The major factors driving the growth of the market in Brazil are due to the increasing burden of cardiovascular diseases and increased adoption of minimally invasive procedures.

According to the 2017 study report by Gagnon-Arpin et al, stated the prevalence of cardiovascular diseases (CVD) in Brazil adults is projected to increase to 13.6 million by 2035, while the economic burden, including both direct and indirect costs, would increase to USD 40 billion.

Furthermore, due to increasing awareness about various heart diseases in Brazil along with the increasing number of the elderly population in the country which is expected to show significant growth over the forecast period.

Brazil Cardiovascular Devices Market Trends

This section covers the major market trends shaping the Brazil Cardiovascular Devices Market according to our research experts:

Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period

An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.

According to the World health organization (WHO) 2017, approximately 164,557 or 15.56% of total deaths were due to coronary heart disease deaths in Brazil in the year 2017 and was considered the highest cause of death. This can be reduced marginally with the effective adoption of cardiovascular devices.

Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Moreover, increasing cardiovascular diseases in the country by adopting these devices can help in monitoring the heart condition. Thus, owing to the above factors the segment is expected to show a healthy growth rate in the near future.

brazil cardiovascular devices market trends

Brazil Cardiovascular Devices Industry Overview

The Brazil cardiovascular devices market is competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Medtronic, Inc (Covidien Plc), Boston Scientific Corporation, Edwards Lifesciences, Abbott Laboratories, Cardinal Health Inc, C.R. Bard, Inc, Terumo Corporation, Braile Biomedica Ltda and Biotronik SE & Co. KG.

Brazil Cardiovascular Devices Market Leaders

  1. Medtronic, Inc (Covidien Plc)

  2. Boston Scientific Corporation

  3. Abbott Laboratories

  4. Cardinal Health Inc

  5. Edwards Lifesciences

*Disclaimer: Major Players sorted in no particular order

Medtronic, Inc (Covidien Plc) Boston Scientific Corporation Abbott Laboratories Cardinal Health Inc Edwards Lifesciences
Need More Details on Market Players and Competitors?
Download PDF

Brazil Cardiovascular Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cardiovascular Diseases
    • 4.2.2 Increased Preference of Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 High Cost of Instruments and Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Electrocardiogram (ECG)
    • 5.1.1.2 Remote Cardiac Monitoring
    • 5.1.1.3 Other Diagnostic and Monitoring Devices
    • 5.1.2 Therapeutic and Surgical Devices
    • 5.1.2.1 Cardiac Assist Devices
    • 5.1.2.2 Cardiac Rhythm Management Device
    • 5.1.2.3 Catheter
    • 5.1.2.4 Grafts
    • 5.1.2.5 Heart Valves
    • 5.1.2.6 Stents
    • 5.1.2.7 Other Therapeutic and Surgical Devices

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic, Inc (Covidien Plc)
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Edwards Lifesciences
    • 6.1.4 Abbott Laboratories
    • 6.1.5 Cardinal Health Inc
    • 6.1.6 C.R. Bard, Inc
    • 6.1.7 Terumo Corporation
    • 6.1.8 Braile Biomedica Ltda
    • 6.1.9 Biotronik SE & Co. KG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Brazil Cardiovascular Devices Industry Segmentation

As per the scope of the report, Cardiovascular diseases are a group of disorders of the heart and blood vessels that includes coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. The cardiovascular devices are used to treat or prevent different cardiovascular conditions. The Brazil Cardiovascular Devices Market is segmented by device type.

By Device Type Diagnostic and Monitoring Devices Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
By Device Type Therapeutic and Surgical Devices Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices
Need A Different Region Or Segment?
Customize Now

Brazil Cardiovascular Devices Market Research FAQs

The Brazil Cardiovascular Devices Market is projected to register a CAGR of 2.5% during the forecast period (2024-2029)

Medtronic, Inc (Covidien Plc), Boston Scientific Corporation, Abbott Laboratories, Cardinal Health Inc and Edwards Lifesciences are the major companies operating in the Brazil Cardiovascular Devices Market.

The report covers the Brazil Cardiovascular Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Brazil Cardiovascular Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Brazil Cardiovascular Devices Industry Report

Statistics for the 2024 Brazil Cardiovascular Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Brazil Cardiovascular Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Brazil Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)